TY - JOUR
T1 - Epidemiology of pain among outpatients in methadone maintenance treatment programs
AU - Dhingra, Lara
AU - Masson, Carmen
AU - Perlman, David C.
AU - Seewald, Randy M.
AU - Katz, Judith
AU - McKnight, Courtney
AU - Homel, Peter
AU - Wald, Emily
AU - Jordan, Ashly E.
AU - Young, Christopher
AU - Portenoy, Russell K.
N1 - Funding Information:
This research was supported by NIDA , R01DA020781 , R01DA020841 , P30DA011041 , P50DA009253 , and U10DA015815 (Perlman, Masson).
PY - 2013/2/1
Y1 - 2013/2/1
N2 - Background: This analysis explored the prevalence and correlates of pain in patients enrolled in methadone maintenance treatment (MMT). Methods: Patients in two MMT programs starting a hepatitis care coordination randomized controlled trial completed the Brief Pain Inventory Short-Form and other questionnaires. Associations between clinically significant pain (average daily pain. ≥. 5 or mean pain interference. ≥. 5 during the past week) and sociodemographic data, medical status, depressive symptoms, and health-related quality of life, and current substance use were evaluated in multivariate analyses. Results: The 489 patients included 31.8% women; 30.3% Hispanics, 29.4% non-Hispanic Blacks, and 36.0% non-Hispanic Whites; 60.1% had hepatitis C, 10.6% had HIV, and 46.8% had moderate or severe depressive symptomatology. Mean methadone dose was 95.7. mg (SD 48.9) and urine drug screening (UDS) was positive for opiates, cocaine, and amphetamines in 32.9%, 40.1%, and 2.9%, respectively. Overall, 237 (48.5%) reported clinically significant pain. Pain treatments included prescribed opioids (38.8%) and non-opioids (48.9%), and self-management approaches (60.8%), including prayer (33.8%), vitamins (29.5%), and distraction (12.7%). Pain was associated with higher methadone dose, more medical comorbidities, prescribed opioid therapy, and more severe depressive symptomatology; it was not associated with UDS or self-reported substance use. Conclusions: Clinically significant pain was reported by almost half of the patients in MMT programs and was associated with medical and psychological comorbidity. Pain was often treated with opioids and was not associated with measures of drug use. Studies are needed to further clarify these associations and determine their importance for pain treatment strategies.
AB - Background: This analysis explored the prevalence and correlates of pain in patients enrolled in methadone maintenance treatment (MMT). Methods: Patients in two MMT programs starting a hepatitis care coordination randomized controlled trial completed the Brief Pain Inventory Short-Form and other questionnaires. Associations between clinically significant pain (average daily pain. ≥. 5 or mean pain interference. ≥. 5 during the past week) and sociodemographic data, medical status, depressive symptoms, and health-related quality of life, and current substance use were evaluated in multivariate analyses. Results: The 489 patients included 31.8% women; 30.3% Hispanics, 29.4% non-Hispanic Blacks, and 36.0% non-Hispanic Whites; 60.1% had hepatitis C, 10.6% had HIV, and 46.8% had moderate or severe depressive symptomatology. Mean methadone dose was 95.7. mg (SD 48.9) and urine drug screening (UDS) was positive for opiates, cocaine, and amphetamines in 32.9%, 40.1%, and 2.9%, respectively. Overall, 237 (48.5%) reported clinically significant pain. Pain treatments included prescribed opioids (38.8%) and non-opioids (48.9%), and self-management approaches (60.8%), including prayer (33.8%), vitamins (29.5%), and distraction (12.7%). Pain was associated with higher methadone dose, more medical comorbidities, prescribed opioid therapy, and more severe depressive symptomatology; it was not associated with UDS or self-reported substance use. Conclusions: Clinically significant pain was reported by almost half of the patients in MMT programs and was associated with medical and psychological comorbidity. Pain was often treated with opioids and was not associated with measures of drug use. Studies are needed to further clarify these associations and determine their importance for pain treatment strategies.
KW - Addiction
KW - Epidemiology
KW - Methadone maintenance
KW - Pain
KW - Pain management
UR - http://www.scopus.com/inward/record.url?scp=84872417479&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84872417479&partnerID=8YFLogxK
U2 - 10.1016/j.drugalcdep.2012.08.003
DO - 10.1016/j.drugalcdep.2012.08.003
M3 - Article
C2 - 22951068
AN - SCOPUS:84872417479
SN - 0376-8716
VL - 128
SP - 161
EP - 165
JO - Drug and alcohol dependence
JF - Drug and alcohol dependence
IS - 1-2
ER -